Which drug class controls and prevents cardiac dysrhythmias?

Which drug class controls and prevents cardiac dysrhythmias?

• A. Antacids
• B. Antidysrhythmic
• C. Antiflatulent
• D. Antianginal

Answer: (B)

Antiarrhythmic drugs are designed to stabilize the heart’s electrical activity, directly addressing rhythm problems. They work by altering how cardiac cells conduct electricity and respond to impulses, which helps suppress abnormal pacemaker activity, slow conduction where needed, and prolong the time before another beat can occur. This combination helps prevent dangerous rhythms and restores a regular heart rhythm. Understanding their actions helps: some drugs block sodium channels to slow the rapid upstroke of the heartbeat, others block beta receptors to reduce sympathetic drive, some prolong the repolarization phase to prevent early re-excitation, and others block calcium channels to slow conduction through the AV node. Together, these mechanisms reduce ectopic activity and break re-entry circuits that cause many dysrhythmias, making them the class specifically focused on rhythm control. Other options don’t target rhythm disorders directly. Antacids deal with stomach acid, antiflatulents relieve gas, and antianginals treat chest pain due to ischemia. While some antianginal drugs (like certain beta-blockers or calcium channel blockers) can influence rhythm, their primary purpose isn’t rhythm control; the class that is defined by preventing and treating abnormal heart rhythms is antidysrhythmic. In short, antidysrhythmic drugs are the ones purpose-built to control and prevent cardiac dysrhythmias by modulating the heart’s electrical activity.

Antiarrhythmic drugs are designed to stabilize the heart’s electrical activity, directly addressing rhythm problems. They work by altering how cardiac cells conduct electricity and respond to impulses, which helps suppress abnormal pacemaker activity, slow conduction where needed, and prolong the time before another beat can occur. This combination helps prevent dangerous rhythms and restores a regular heart rhythm.

Understanding their actions helps: some drugs block sodium channels to slow the rapid upstroke of the heartbeat, others block beta receptors to reduce sympathetic drive, some prolong the repolarization phase to prevent early re-excitation, and others block calcium channels to slow conduction through the AV node. Together, these mechanisms reduce ectopic activity and break re-entry circuits that cause many dysrhythmias, making them the class specifically focused on rhythm control.

Other options don’t target rhythm disorders directly. Antacids deal with stomach acid, antiflatulents relieve gas, and antianginals treat chest pain due to ischemia. While some antianginal drugs (like certain beta-blockers or calcium channel blockers) can influence rhythm, their primary purpose isn’t rhythm control; the class that is defined by preventing and treating abnormal heart rhythms is antidysrhythmic.

In short, antidysrhythmic drugs are the ones purpose-built to control and prevent cardiac dysrhythmias by modulating the heart’s electrical activity.